Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer

LESSONS LEARNED: Oraxol, a novel oral formulation of paclitaxel, displayed modest efficacy as second-line chemotherapy for gastric cancer. Considering its favorable toxicity profiles, further studies are warranted in various solid tumors including gastric cancer. BACKGROUND. Oraxol consists of pacli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Lee, Keun-Wook, Lee, Kyung Hee, Zang, Dae Young, Park, Young Iee, Shin, Dong Bok, Kim, Jin Won, Im, Seock-Ah, Koh, Sung Ae, Yu, Kyung-Sang, Cho, Joo-Youn, Jung, Jin-A, Bang, Yung-Jue
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4524762/
https://ncbi.nlm.nih.gov/pubmed/26112004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0202
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados